Basalog 100

Composition of Basalog 100

Basalog 100 contains Insulin glargine 100 IU/mL (3 mL prefilled pen/cartridge; total 300 IU). It belongs to the Long-acting insulin analogue (basal insulin) class of medicines.

Uses of Basalog 100

Management of diabetes mellitus to improve glycaemic control in adults and children where basal (long-acting) insulin is required; Type 1 diabetes (with short/rapid-acting insulin) and Type 2 diabetes (alone or with oral antidiabetics/other insulin).

Key benefits

• Provides 24-hour basal insulin coverage
• Helps control fasting blood glucose
• Reduces HbA1c with regular use
• Once-daily dosing convenience
• Suitable for Type 1 (with bolus insulin) and Type 2 diabetes

How Basalog 100 works

Insulin glargine is a long-acting basal insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a relatively constant glucose-lowering effect over ~24 hours by increasing peripheral glucose uptake and reducing hepatic glucose production.

How to take Basalog 100

For subcutaneous use only. Inject once daily at the same time each day into abdomen, thigh or upper arm; rotate injection sites. Use as prescribed based on blood glucose; do not dilute or mix with other insulins in the same syringe/pen. Check label and appearance before use; never inject intravenously.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Basalog as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Basalog than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Basalog 100

Most side effects of Basalog are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia
• injection site reactions (pain/redness/swelling/itching)
• weight gain
• lipodystrophy at injection site
• oedema
• rash

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Basalog 100

Warnings and precautions

Risk of hypoglycaemia—monitor blood glucose, especially when changing dose, meal pattern, activity or other medicines. Do not use during episodes of hypoglycaemia. Use caution in renal/hepatic impairment, elderly, and those with hypoglycaemia unawareness. Rotate injection sites to reduce lipodystrophy. Do not share pens/needles to prevent infection transmission. Seek urgent care for severe hypoglycaemia, allergic reactions, or signs of infection.

Interactions with other medicines

Other antidiabetics (sulfonylureas, glinides) and alcohol may increase hypoglycaemia risk; beta-blockers can mask hypoglycaemia symptoms; corticosteroids, thiazide/loop diuretics, thyroid hormones, sympathomimetics and atypical antipsychotics may increase blood glucose; ACE inhibitors/ARBs and salicylates may enhance glucose-lowering; MAO inhibitors may increase hypoglycaemia risk.

How to store Basalog 100

Store unopened in a refrigerator at 2–8°C; do not freeze and keep away from freezer compartment. Protect from light. After first use, keep as per pack instructions (often at room temperature below 25–30°C) and use within the in-use period; do not refrigerate if label advises; keep cap on and avoid heat/sunlight.

Manufacturer and class

Manufacturer:

BIOCON LTD`

Therapeutic class:

Antidiabetic

Drug class:

Long-acting insulin analogue (basal insulin)